BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 10698519)

  • 1. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
    Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
    Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
    Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
    Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma.
    Bläker H; Hofmann WJ; Rieker RJ; Penzel R; Graf M; Otto HF
    Genes Chromosomes Cancer; 1999 Aug; 25(4):399-402. PubMed ID: 10398436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.
    Koch A; Denkhaus D; Albrecht S; Leuschner I; von Schweinitz D; Pietsch T
    Cancer Res; 1999 Jan; 59(2):269-73. PubMed ID: 9927029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
    Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam.
    Anna CH; Sills RC; Foley JF; Stockton PS; Ton TV; Devereux TR
    Cancer Res; 2000 Jun; 60(11):2864-8. PubMed ID: 10850429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma.
    Takayasu H; Horie H; Hiyama E; Matsunaga T; Hayashi Y; Watanabe Y; Suita S; Kaneko M; Sasaki F; Hashizume K; Ozaki T; Furuuchi K; Tada M; Ohnuma N; Nakagawara A
    Clin Cancer Res; 2001 Apr; 7(4):901-8. PubMed ID: 11309340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas.
    Koch A; Weber N; Waha A; Hartmann W; Denkhaus D; Behrens J; Birchmeier W; von Schweinitz D; Pietsch T
    J Pathol; 2004 Dec; 204(5):546-54. PubMed ID: 15538750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors.
    Yamaoka H; Ohtsu K; Sueda T; Yokoyama T; Hiyama E
    Oncol Rep; 2006 Mar; 15(3):551-6. PubMed ID: 16465411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient.
    Inukai T; Furuuchi K; Sugita K; Uno K; Ooi A; Sasaki F; Hamada J; Moriuchi T; Nakazawa S
    Oncol Rep; 2004 Jan; 11(1):121-6. PubMed ID: 14654913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
    Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway.
    Torbenson M; Lee JH; Choti M; Gage W; Abraham SC; Montgomery E; Boitnott J; Wu TT
    Mod Pathol; 2002 Mar; 15(3):189-96. PubMed ID: 11904335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific expression of beta-catenin in normal mesenchyme and uveal melanomas and its effect on invasiveness.
    Kim K; Daniels KJ; Hay ED
    Exp Cell Res; 1998 Nov; 245(1):79-90. PubMed ID: 9828103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
    Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
    Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors.
    Takahashi M; Fukuda K; Sugimura T; Wakabayashi K
    Cancer Res; 1998 Jan; 58(1):42-6. PubMed ID: 9426055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Catenin mutations in 2 nested stromal epithelial tumors of the liver--a neoplasia with defective mesenchymal-epithelial transition.
    Assmann G; Kappler R; Zeindl-Eberhart E; Schmid I; Häberle B; Graeb C; Jung A; Müller-Höcker J
    Hum Pathol; 2012 Nov; 43(11):1815-27. PubMed ID: 22749188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma.
    Kato K; Nakatani Y; Kanno H; Inayama Y; Ijiri R; Nagahara N; Miyake T; Tanaka M; Ito Y; Aida N; Tachibana K; Sekido K; Tanaka Y
    J Pathol; 2004 Jul; 203(3):814-21. PubMed ID: 15221941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-catenin is a target for the ubiquitin-proteasome pathway.
    Aberle H; Bauer A; Stappert J; Kispert A; Kemler R
    EMBO J; 1997 Jul; 16(13):3797-804. PubMed ID: 9233789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
    Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P
    J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
    Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
    Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.